{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T18:25:40Z","timestamp":1778696740939,"version":"3.51.4"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,11,8]],"date-time":"2017-11-08T00:00:00Z","timestamp":1510099200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["675121"],"award-info":[{"award-number":["675121"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Comput Aided Mol Des"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1007\/s10822-017-0075-9","type":"journal-article","created":{"date-parts":[[2017,11,8]],"date-time":"2017-11-08T00:00:03Z","timestamp":1510099203000},"page":"21-44","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Using physics-based pose predictions and free energy perturbation calculations to predict binding poses and relative binding affinities for FXR ligands in the D3R Grand Challenge 2"],"prefix":"10.1007","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2973-3550","authenticated-orcid":false,"given":"Christina","family":"Athanasiou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1008-7264","authenticated-orcid":false,"given":"Sofia","family":"Vasilakaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitris","family":"Dellis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9287-364X","authenticated-orcid":false,"given":"Zoe","family":"Cournia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,11,8]]},"reference":[{"issue":"7","key":"75_CR1","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1002\/cmdc.201200104","volume":"7","author":"AW Baggett","year":"2012","unstructured":"Baggett AW et al (2012) Structural characterization and computer-aided optimization of a small-molecule inhibitor of the Arp2\/3 complex, a key regulator of the actin cytoskeleton. ChemMedChem 7(7):1286\u20131294","journal-title":"ChemMedChem"},{"issue":"2","key":"75_CR2","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1021\/ct300899n","volume":"9","author":"P Gkeka","year":"2013","unstructured":"Gkeka P et al (2013) Free energy calculations reveal the origin of binding preference for aminoadamantane blockers of influenza A\/M2TM pore. J Chem Theory Comput 9(2):1272\u20131281","journal-title":"J Chem Theory Comput"},{"issue":"16","key":"75_CR3","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.2174\/1568026614666140929124445","volume":"14","author":"E Lionta","year":"2014","unstructured":"Lionta E et al (2014) Structure-based virtual screening for drug discovery: principles, applications and recent advances. Curr Top Med Chem 14(16):1923\u20131938","journal-title":"Curr Top Med Chem"},{"issue":"9","key":"75_CR4","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s10822-016-9946-8","volume":"30","author":"S Gathiaka","year":"2016","unstructured":"Gathiaka S et al (2016) D3R grand challenge 2015: evaluation of protein-ligand pose and affinity predictions. J Comput Aided Mol Des 30(9):651\u2013668","journal-title":"J Comput Aided Mol Des"},{"issue":"20","key":"75_CR5","doi-asserted-by":"crossref","first-page":"4890","DOI":"10.1016\/j.bmc.2016.07.044","volume":"24","author":"ASJS Mey","year":"2016","unstructured":"Mey ASJS et al (2016) Blinded predictions of binding modes and energies of HSP90-\u03b1 ligands for the 2015 D3R grand challenge. Bioorg Med Chem 24(20):4890\u20134899","journal-title":"Bioorg Med Chem"},{"issue":"9","key":"75_CR6","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/s10822-016-9942-z","volume":"30","author":"M Misini Ignjatovic","year":"2016","unstructured":"Misini Ignjatovic M et al (2016) Binding-affinity predictions of HSP90 in the D3R Grand Challenge 2015 with docking, MM\/GBSA, QM\/MM, and free-energy simulations. J Comput Aided Mol Des 30(9):707\u2013730","journal-title":"J Comput Aided Mol Des"},{"issue":"26","key":"75_CR7","doi-asserted-by":"crossref","first-page":"8225","DOI":"10.1021\/ja0709728","volume":"129","author":"KL Damm","year":"2007","unstructured":"Damm KL, Carlson HA (2007) Exploring experimental sources of multiple protein conformations in structure-based drug design. J Am Chem Soc 129(26):8225\u20138235","journal-title":"J Am Chem Soc"},{"issue":"2","key":"75_CR8","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1006\/jmbi.1996.0776","volume":"266","author":"RM Knegtel","year":"1997","unstructured":"Knegtel RM, Kuntz ID, Oshiro CM (1997) Molecular docking to ensembles of protein structures. J Mol Biol 266(2):424\u2013440","journal-title":"J Mol Biol"},{"issue":"2","key":"75_CR9","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.sbi.2008.01.004","volume":"18","author":"M Totrov","year":"2008","unstructured":"Totrov M, Abagyan R (2008) Flexible ligand docking to multiple receptor conformations: a practical alternative. Curr Opin Struct Biol 18(2):178\u2013184","journal-title":"Curr Opin Struct Biol"},{"issue":"3","key":"75_CR10","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nrd3078","volume":"9","author":"SM Paul","year":"2010","unstructured":"Paul SM et al (2010) How to improve R&D productivity: the pharmaceutical industry\u2019s Grand Challenge. Nat Rev Drug Discov 9(3):203\u2013214","journal-title":"Nat Rev Drug Discov"},{"issue":"7","key":"75_CR11","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1021\/ja512751q","volume":"137","author":"L Wang","year":"2015","unstructured":"Wang L et al (2015) Accurate and reliable prediction of relative ligand binding potency in prospective drug discovery by way of a modern free-energy calculation protocol and force field. J Am Chem Soc 137(7):2695\u20132703","journal-title":"J Am Chem Soc"},{"key":"75_CR12","unstructured":"Christ CD (2016) Binding affinity prediction from molecular simulations: a new standard method in structure-based drug design? Available from https:\/\/f1000research.com\/slides\/5-1761"},{"issue":"1","key":"75_CR13","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1021\/ci4004199","volume":"54","author":"CD Christ","year":"2014","unstructured":"Christ CD, Fox T (2014) Accuracy assessment and automation of free energy calculations for drug design. J Chem Inf Model 54(1):108\u2013120","journal-title":"J Chem Inf Model"},{"issue":"2","key":"75_CR14","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/cmdc.201500333","volume":"11","author":"F Lovering","year":"2016","unstructured":"Lovering F et al (2016) Imidazotriazines: spleen tyrosine kinase (Syk) inhibitors identified by free-energy perturbation (FEP). ChemMedChem 11(2):217\u2013233","journal-title":"ChemMedChem"},{"issue":"3","key":"75_CR15","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s10822-016-9998-9","volume":"31","author":"H Vlijmen van","year":"2017","unstructured":"van Vlijmen H, Desjarlais RL, Mirzadegan T (2017) Computational chemistry at Janssen. J Comput Aided Mol Des 31(3):267\u2013273","journal-title":"J Comput Aided Mol Des"},{"issue":"16","key":"75_CR16","doi-asserted-by":"crossref","first-page":"4733","DOI":"10.1016\/j.bmcl.2009.06.062","volume":"19","author":"A Akwabi-Ameyaw","year":"2009","unstructured":"Akwabi-Ameyaw A et al (2009) FXR agonist activity of conformationally constrained analogs of GW 4064. Bioorg Med Chem Lett 19(16):4733\u20134739","journal-title":"Bioorg Med Chem Lett"},{"issue":"20","key":"75_CR17","doi-asserted-by":"crossref","first-page":"6154","DOI":"10.1016\/j.bmcl.2011.08.034","volume":"21","author":"A Akwabi-Ameyaw","year":"2011","unstructured":"Akwabi-Ameyaw A et al (2011) Conformationally constrained farnesoid X receptor (FXR) agonists: alternative replacements of the stilbene. Bioorg Med Chem Lett 21(20):6154\u20136160","journal-title":"Bioorg Med Chem Lett"},{"issue":"11","key":"75_CR18","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.1016\/j.bmcl.2009.04.047","volume":"19","author":"JY Bass","year":"2009","unstructured":"Bass JY et al (2009) Substituted isoxazole analogs of farnesoid X receptor (FXR) agonist GW4064. Bioorg Med Chem Lett 19(11):2969\u20132973","journal-title":"Bioorg Med Chem Lett"},{"issue":"4","key":"75_CR19","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/S1097-2765(03)00104-7","volume":"11","author":"M Downes","year":"2003","unstructured":"Downes M et al (2003) A chemical, genetic, and structural analysis of the nuclear bile acid receptor FXR. Mol Cell 11(4):1079\u20131092","journal-title":"Mol Cell"},{"issue":"9","key":"75_CR20","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1016\/j.bmcl.2009.03.008","volume":"19","author":"S Feng","year":"2009","unstructured":"Feng S et al (2009) Identification of an N-oxide pyridine GW4064 analog as a potent FXR agonist. Bioorg Med Chem Lett 19(9):2595\u20132598","journal-title":"Bioorg Med Chem Lett"},{"issue":"4","key":"75_CR21","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1021\/jm8014124","volume":"52","author":"B Flatt","year":"2009","unstructured":"Flatt B et al (2009) Discovery of XL335 (WAY-362450), a highly potent, selective, and orally active agonist of the farnesoid X receptor (FXR). J Med Chem 52(4):904\u2013907","journal-title":"J Med Chem"},{"key":"75_CR22","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1038\/ncomms2924","volume":"4","author":"L Jin","year":"2013","unstructured":"Jin L et al (2013) The antiparasitic drug ivermectin is a novel FXR ligand that regulates metabolism. Nat Commun 4:1937","journal-title":"Nat Commun"},{"issue":"4","key":"75_CR23","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1021\/jm901650u","volume":"53","author":"JT Lundquist","year":"2010","unstructured":"Lundquist JT et al (2010) Improvement of physiochemical properties of the tetrahydroazepinoindole series of farnesoid X receptor (FXR) agonists: beneficial modulation of lipids in primates. J Med Chem 53(4):1774\u20131787","journal-title":"J Med Chem"},{"issue":"4","key":"75_CR24","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/S1097-2765(03)00112-6","volume":"11","author":"LZ Mi","year":"2003","unstructured":"Mi LZ et al (2003) Structural basis for bile acid binding and activation of the nuclear receptor FXR. Mol Cell 11(4):1093\u20131100","journal-title":"Mol Cell"},{"issue":"4","key":"75_CR25","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/j.bmcl.2010.12.123","volume":"21","author":"HG Richter","year":"2011","unstructured":"Richter HG et al (2011) Optimization of a novel class of benzimidazole-based farnesoid X receptor (FXR) agonists to improve physicochemical and ADME properties. Bioorg Med Chem Lett 21(4):1134\u20131140","journal-title":"Bioorg Med Chem Lett"},{"issue":"1","key":"75_CR26","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.bmcl.2010.11.039","volume":"21","author":"HG Richter","year":"2011","unstructured":"Richter HG et al (2011) Discovery of novel and orally active FXR agonists for the potential treatment of dyslipidemia and diabetes. Bioorg Med Chem Lett 21(1):191\u2013194","journal-title":"Bioorg Med Chem Lett"},{"issue":"14","key":"75_CR27","doi-asserted-by":"crossref","first-page":"5337","DOI":"10.1073\/pnas.0710981105","volume":"105","author":"SM Soisson","year":"2008","unstructured":"Soisson SM et al (2008) Identification of a potent synthetic FXR agonist with an unexpected mode of binding and activation. Proc Natl Acad Sci USA 105(14):5337\u20135342","journal-title":"Proc Natl Acad Sci USA"},{"issue":"32","key":"75_CR28","doi-asserted-by":"crossref","first-page":"19888","DOI":"10.1074\/jbc.M114.630475","volume":"290","author":"X Xu","year":"2015","unstructured":"Xu X et al (2015) Structural basis for small molecule NDB (N-benzyl-N-(3-(tert-butyl)-4-hydroxyphenyl)-2,6-dichloro-4-(dimethylamino) benzamide) as a selective antagonist of farnesoid X receptor alpha (FXRalpha) in stabilizing the homodimerization of the receptor. J Biol Chem 290(32):19888\u201319899","journal-title":"J Biol Chem"},{"issue":"22","key":"75_CR29","doi-asserted-by":"crossref","first-page":"8505","DOI":"10.1021\/ja00204a027","volume":"111","author":"LX Dang","year":"1989","unstructured":"Dang LX, Merz KM, Kollman PA (1989) Free energy calculations on protein stability: Thr-157 .fwdarw. Val-157 mutation of T4 lysozyme. J Am Chem Soc 111(22):8505\u20138508","journal-title":"J Am Chem Soc"},{"issue":"5","key":"75_CR30","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1021\/ar00161a004","volume":"22","author":"WL Jorgensen","year":"1989","unstructured":"Jorgensen WL (1989) Free energy calculations: a breakthrough for modeling organic chemistry in solution. Acc Chem Res 22(5):184\u2013189","journal-title":"Acc Chem Res"},{"issue":"6","key":"75_CR31","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1021\/ar800236t","volume":"42","author":"WL Jorgensen","year":"2009","unstructured":"Jorgensen WL (2009) Efficient drug lead discovery and optimization. Acc Chem Res 42(6):724\u2013733","journal-title":"Acc Chem Res"},{"issue":"6","key":"75_CR32","doi-asserted-by":"crossref","first-page":"3050","DOI":"10.1063\/1.449208","volume":"83","author":"WL Jorgensen","year":"1985","unstructured":"Jorgensen WL, Ravimohan C (1985) Monte Carlo simulation of differences in free energies of hydration. J Chem Phys 83(6):3050\u20133054","journal-title":"J Chem Phys"},{"issue":"6","key":"75_CR33","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1021\/ct800011m","volume":"4","author":"WL Jorgensen","year":"2008","unstructured":"Jorgensen WL, Thomas LL (2008) Perspective on free-energy perturbation calculations for chemical equilibria. J Chem Theory Comput 4(6):869\u2013876","journal-title":"J Chem Theory Comput"},{"issue":"7","key":"75_CR34","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1021\/cr00023a004","volume":"93","author":"P Kollman","year":"1993","unstructured":"Kollman P (1993) Free energy calculations: applications to chemical and biochemical phenomena. Chem Rev 93(7):2395\u20132417","journal-title":"Chem Rev"},{"issue":"8","key":"75_CR35","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1021\/ar00176a002","volume":"23","author":"PA Kollman","year":"1990","unstructured":"Kollman PA, Merz KM (1990) Computer modeling of the interactions of complex molecules. Acc Chem Res 23(8):246\u2013252","journal-title":"Acc Chem Res"},{"issue":"15","key":"75_CR36","doi-asserted-by":"crossref","first-page":"5649","DOI":"10.1021\/ja00197a022","volume":"111","author":"KM Merz","year":"1989","unstructured":"Merz KM, Kollman PA (1989) Free energy perturbation simulations of the inhibition of thermolysin: prediction of the free energy of binding of a new inhibitor. J Am Chem Soc 111(15):5649\u20135658","journal-title":"J Am Chem Soc"},{"issue":"4","key":"75_CR37","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0097-8485(84)85020-2","volume":"8","author":"BL Tembre","year":"1984","unstructured":"Tembre BL, Mc JA, Cammon (1984) Ligand-receptor interactions. Comput Chem 8(4):281\u2013283","journal-title":"Comput Chem"},{"key":"75_CR38","unstructured":"Small-Molecule Drug Discovery Suite 2016-2, Schr\u00f6dinger, LLC, New York, NY, 2016"},{"key":"75_CR39","unstructured":"Schr\u00f6dinger Release 2016-2: Canvas, Schr\u00f6dinger, LLC, New York, NY, 2016"},{"key":"75_CR40","unstructured":"Schr\u00f6dinger Release 2016-2: LigPrep, Schr\u00f6dinger, LLC, New York, NY, 2016"},{"key":"75_CR41","unstructured":"Schr\u00f6dinger Release 2016-2: Schr\u00f6dinger Suite 2016-2 Protein Preparation Wizard; Epik, Schr\u00f6dinger, LLC, New York, NY, 2016; Impact, Schr\u00f6dinger, LLC, New York, NY, 2016; Prime, Schr\u00f6dinger, LLC, New York, NY, 2016"},{"issue":"3","key":"75_CR42","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s10822-013-9644-8","volume":"27","author":"GM Sastry","year":"2013","unstructured":"Sastry GM et al (2013) Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments. J Comput Aided Mol Des 27(3):221\u2013234","journal-title":"J Comput Aided Mol Des"},{"key":"75_CR43","unstructured":"Schr\u00f6dinger Release 2016-2: WaterMap, Schr\u00f6dinger, LLC, New York, NY, 2016"},{"issue":"9","key":"75_CR44","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1021\/ja0771033","volume":"130","author":"R Abel","year":"2008","unstructured":"Abel R et al (2008) Role of the active-site solvent in the thermodynamics of factor Xa ligand binding. J Am Chem Soc 130(9):2817\u20132831","journal-title":"J Am Chem Soc"},{"issue":"3","key":"75_CR45","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1073\/pnas.0610202104","volume":"104","author":"T Young","year":"2007","unstructured":"Young T et al (2007) Motifs for molecular recognition exploiting hydrophobic enclosure in protein-ligand binding. Proc Natl Acad Sci USA 104(3):808\u2013813","journal-title":"Proc Natl Acad Sci USA"},{"key":"75_CR46","unstructured":"Schr\u00f6dinger Release 2016-2: Glide, Schr\u00f6dinger, LLC, New York, NY, 2016"},{"issue":"7","key":"75_CR47","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1021\/jm0306430","volume":"47","author":"RA Friesner","year":"2004","unstructured":"Friesner RA et al (2004) Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. J Med Chem 47(7):1739\u20131749","journal-title":"J Med Chem"},{"issue":"7","key":"75_CR48","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1021\/jm030644s","volume":"47","author":"TA Halgren","year":"2004","unstructured":"Halgren TA et al (2004) Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening. J Med Chem 47(7):1750\u20131759","journal-title":"J Med Chem"},{"issue":"21","key":"75_CR49","doi-asserted-by":"crossref","first-page":"6177","DOI":"10.1021\/jm051256o","volume":"49","author":"RA Friesner","year":"2006","unstructured":"Friesner RA et al (2006) Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes. J Med Chem 49(21):6177\u20136196","journal-title":"J Med Chem"},{"key":"75_CR50","unstructured":"Schr\u00f6dinger Release 2016-2: Phase, Schr\u00f6dinger, LLC, New York, NY, 2016"},{"issue":"10","key":"75_CR51","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1021\/ci2002704","volume":"51","author":"GM Sastry","year":"2011","unstructured":"Sastry GM, Dixon SL, Sherman W (2011) Rapid shape-based ligand alignment and virtual screening method based on atom\/feature-pair similarities and volume overlap scoring. J Chem Inf Model 51(10):2455\u20132466","journal-title":"J Chem Inf Model"},{"issue":"2","key":"75_CR52","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1021\/jm030331x","volume":"47","author":"Z Deng","year":"2004","unstructured":"Deng Z, Chuaqui C, Singh J (2004) Structural interaction fingerprint (SIFt): a novel method for analyzing three-dimensional protein-ligand binding interactions. J Med Chem 47(2):337\u2013344","journal-title":"J Med Chem"},{"issue":"1","key":"75_CR53","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1747-0285.2005.00323.x","volume":"67","author":"J Singh","year":"2006","unstructured":"Singh J et al (2006) Structural interaction fingerprints: a new approach to organizing, mining, analyzing, and designing protein-small molecule complexes. Chem Biol Drug Des 67(1):5\u201312","journal-title":"Chem Biol Drug Des"},{"issue":"10\u201311","key":"75_CR54","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s10822-006-9087-6","volume":"20","author":"SL Dixon","year":"2006","unstructured":"Dixon SL et al (2006) PHASE: a new engine for pharmacophore perception, 3D QSAR model development, and 3D database screening: 1. Methodology and preliminary results. J Comput Aided Mol Des 20(10\u201311):647\u2013671","journal-title":"J Comput Aided Mol Des"},{"key":"75_CR55","unstructured":"Schr\u00f6dinger Release 2016-2: Jaguar, Schr\u00f6dinger, LLC, New York, NY, 2016"},{"issue":"18","key":"75_CR56","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1002\/qua.24481","volume":"113","author":"AD Bochevarov","year":"2013","unstructured":"Bochevarov AD et al (2013) Jaguar: a high-performance quantum chemistry software program with strengths in life and materials sciences. Int J Quantum Chem 113(18):2110\u20132142","journal-title":"Int J Quantum Chem"},{"key":"75_CR57","unstructured":"Schr\u00f6dinger Release 2016-2: Schr\u00f6dinger Suite 2016-2 Induced Fit Docking protocol; Glide, Schr\u00f6dinger, LLC, New York, NY, 2016; Prime, Schr\u00f6dinger, LLC, New York, NY, 2016"},{"issue":"9","key":"75_CR58","doi-asserted-by":"crossref","first-page":"3160","DOI":"10.1016\/j.bmc.2005.12.032","volume":"14","author":"R Farid","year":"2006","unstructured":"Farid R et al (2006) New insights about HERG blockade obtained from protein modeling, potential energy mapping, and docking studies. Bioorg Med Chem 14(9):3160\u20133173","journal-title":"Bioorg Med Chem"},{"issue":"1","key":"75_CR59","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1747-0285.2005.00327.x","volume":"67","author":"W Sherman","year":"2006","unstructured":"Sherman W, Beard HS, Farid R (2006) Use of an induced fit receptor structure in virtual screening. Chem Biol Drug Des 67(1):83\u201384","journal-title":"Chem Biol Drug Des"},{"issue":"2","key":"75_CR60","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1021\/jm050540c","volume":"49","author":"W Sherman","year":"2006","unstructured":"Sherman W et al (2006) Novel procedure for modeling ligand\/receptor induced fit effects. J Med Chem 49(2):534\u2013553","journal-title":"J Med Chem"},{"issue":"6","key":"75_CR61","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1021\/acs.jctc.6b00201","volume":"12","author":"AJ Clark","year":"2016","unstructured":"Clark AJ et al (2016) Prediction of protein-ligand binding poses via a combination of induced fit docking and metadynamics simulations. J Chem Theory Comput 12(6):2990\u20132998","journal-title":"J Chem Theory Comput"},{"issue":"5","key":"75_CR62","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1021\/ci100062n","volume":"50","author":"M Sastry","year":"2010","unstructured":"Sastry M et al (2010) Large-scale systematic analysis of 2D fingerprint methods and parameters to improve virtual screening enrichments. J Chem Inf Model 50(5):771\u2013784","journal-title":"J Chem Inf Model"},{"issue":"49","key":"75_CR63","doi-asserted-by":"crossref","first-page":"15813","DOI":"10.1021\/jp805529z","volume":"112","author":"R Zhou","year":"2008","unstructured":"Zhou R, Das P, Royyuru AK (2008) Single mutation induced H3N2 hemagglutinin antibody neutralization: a free energy perturbation study. J Phys Chem B 112(49):15813\u201315820","journal-title":"J Phys Chem B"},{"issue":"22","key":"75_CR64","doi-asserted-by":"crossref","first-page":"224501","DOI":"10.1063\/1.2201698","volume":"124","author":"MA Kastenholz","year":"2006","unstructured":"Kastenholz MA, Hunenberger PH (2006) Computation of methodology-independent ionic solvation free energies from molecular simulations. II. The hydration free energy of the sodium cation. J Chem Phys 124(22):224501","journal-title":"J Chem Phys"},{"issue":"12","key":"75_CR65","doi-asserted-by":"crossref","first-page":"124106","DOI":"10.1063\/1.2172593","volume":"124","author":"MA Kastenholz","year":"2006","unstructured":"Kastenholz MA, Hunenberger PH (2006) Computation of methodology-independent ionic solvation free energies from molecular simulations. I. The electrostatic potential in molecular liquids. J Chem Phys 124(12):124106","journal-title":"J Chem Phys"},{"issue":"4","key":"75_CR66","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1021\/jp951011v","volume":"100","author":"G Hummer","year":"1996","unstructured":"Hummer G, Pratt LR, Garc\u00eda AE (1996) Free energy of ionic hydration. J Phys Chem 100(4):1206\u20131215","journal-title":"J Phys Chem"},{"issue":"6","key":"75_CR67","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1021\/acs.jctc.5b00214","volume":"11","author":"JW Kaus","year":"2015","unstructured":"Kaus JW et al (2015) How to deal with multiple binding poses in alchemical relative protein-ligand binding free energy calculations. J Chem Theory Comput 11(6):2670\u20132679","journal-title":"J Chem Theory Comput"},{"issue":"9","key":"75_CR68","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/s10822-013-9678-y","volume":"27","author":"S Liu","year":"2013","unstructured":"Liu S et al (2013) Lead optimization mapper: automating free energy calculations for lead optimization. J Comput Aided Mol Des 27(9):755\u2013770","journal-title":"J Comput Aided Mol Des"},{"issue":"2","key":"75_CR69","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0021-9991(76)90078-4","volume":"22","author":"CH Bennett","year":"1976","unstructured":"Bennett CH (1976) Efficient estimation of free energy differences from Monte Carlo data. J Comput Phys 22(2):245\u2013268","journal-title":"J Comput Phys"},{"issue":"2","key":"75_CR70","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1021\/ct300911a","volume":"9","author":"L Wang","year":"2013","unstructured":"Wang L et al (2013) Modeling local structural rearrangements using FEP\/REST: application to relative binding affinity predictions of CDK2 inhibitors. J Chem Theory Comput 9(2):1282\u20131293","journal-title":"J Chem Theory Comput"},{"issue":"23","key":"75_CR71","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1016\/0006-2952(73)90196-2","volume":"22","author":"Y Cheng","year":"1973","unstructured":"Cheng Y, Prusoff WH (1973) Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem Pharmacol 22(23):3099\u20133108","journal-title":"Biochem Pharmacol"}],"container-title":["Journal of Computer-Aided Molecular Design"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10822-017-0075-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-017-0075-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-017-0075-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,5]],"date-time":"2019-10-05T15:59:19Z","timestamp":1570291159000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10822-017-0075-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,8]]},"references-count":71,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["75"],"URL":"https:\/\/doi.org\/10.1007\/s10822-017-0075-9","relation":{},"ISSN":["0920-654X","1573-4951"],"issn-type":[{"value":"0920-654X","type":"print"},{"value":"1573-4951","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,8]]}}}